Risk factors for drug-induced gingival overgrowth

2000 ◽  
Vol 27 (4) ◽  
pp. 217-223 ◽  
Author(s):  
R. A. Seymour ◽  
J. S. Ellis ◽  
J. M. Thomason
Keyword(s):  
Risk Factors ◽  
Drug Induced ◽  
Gingival Overgrowth

scholarly journals Bibliometric Analysis of Research Trends And Characteristics of Drug-Induced Gingival Overgrowth

2021 ◽  
Author(s):  
Ruonan Zhang ◽  
Jie Wu ◽  
Xiaoxiao Wang ◽  
Jiangyuan Song
Keyword(s):  
Risk Factors ◽  
Bibliometric Analysis ◽  
Scientific Evidence ◽  
Close Relation ◽  
Research Trend ◽  
Drug Induced ◽  
Gingival Overgrowth ◽  
The Mean ◽  
High Level ◽  
Number Of Citations

Abstract Objectives: Drug-induced gingival overgrowth (DIGO) is a common adverse drug reaction generally caused by the cyclosporine, phenytoin and nifedipine which belong to the category of immunosuppressant, anticonvulsant and calcium channel blocker respectively. The objective of the bibliometric analysis was to depict main citation characteristics and analyze research trend in the field of DIGO.Methods: An exhaustive search was performed in the Scopus database for the bibliometric list of DIGO in the syntax. The information related to the number of citations, drugs related to DIGO, study topic and design, authorship, year of publication, journal, contributing institution, country of origin and department was extracted.Results: A total of 399 papers on DIGO were retrieved. The total number of citations and that after removal of self-citations is 7814 and 7314, respectively. The mean number of citations is 19.6, with a range of 0 to 608. Article (76.9%) and review (19.5%) are the main paper types. A remarkable increasing trend in the number of citations is observed since 1994. Cyclosporine (45%) is the most common used drug which has close relation with DIGO, followed by nifedipine, phenytoin (both are 18%), amlodipine (7%). Review (28%) constitutes the most design in the study of DIGO. According to the top 20 keywords, the risk factors and pathogenesis of DIGO have been the hot area of research for several years.Conclusions: The bibliometric study is the first of its kind to identify the top-cited articles and their main characteristics and research trend of DIGO. Risk factors and pathogenesis is the hotspot of research in the field of DIGO. More high level of scientific evidence on DIGO, such as systematic reviews and randomized controlled trials, are encouraged to serve as good helper to reduce the incidence and severity of DIGO.

scholarly journals Prevalence and Risk F alence and Risk Factors of Drug-induced Gingiv ors of Drug-induced Gingival Overgrowth in Hypertensive Patients

2021 ◽  
Vol 28 (1) ◽  
Author(s):  
Haslina Taib ◽  
◽  
Muhammad Haziq Mohd Radzwan ◽  
Muhammad Annurdin Sabaruddin ◽  
Wan Majdiah Wan Mohamad ◽  
...  
Keyword(s):  
Risk Factors ◽  
Oral Hygiene ◽  
Antihypertensive Drugs ◽  
Demographic Data ◽  
Significant Risk ◽  
Channel Blockers ◽  
Drug Induced ◽  
Cross Sectional ◽  
Hypertensive Patients ◽  
Gingival Overgrowth

Gingival overgrowth (GO) or enlargement is an unwanted effect occurring on the gingiva that commonly associated with medications. Hypertension is a global burden systemic conditions and showed high prevalent and more patients are taking antihypertensive drugs. Objective: This study aimed to assess the prevalence of drug-induced gingival overgrowth (DIGO) and its associated risk factors among hypertensive patients attending Hospital Universiti Sains Malaysia, Kelantan, Malaysia. Methods: A total of 42 patients with the mean age of 57.1 (SD=9.3) years had participated in this cross-sectional study. They were recruited if they had consumed anti-hypertensive agents for at least 6 months. Demographic data and oral hygiene status were recorded and the presence of DIGO was assessed based on clinical index for gingival overgrowth. Data were analyzed using SPSS version 24.0 with p< 0.05 is considered statistically significant. Results: Majority of patients were taking calcium channel blockers (CCB) (81.0%) with amlodipine reported as the most common antihypertensive prescribed (47.6%). About 52% presented with DIGO and among them 55.9% were in those on CCB by which 9.5% presented with clinically significant enlargement. Except for gingivitis, oral hygiene status and demographic data were not significant risk factors for DIGO (p > 0.05). Conclusion: We found that DIGO is prevalent among hypertensive patients on CCB and its occurrence is coexists with gingivitis. Therefore, periodontal assessment is recommended among these patients for early detection and management of drug-induced gingival overgrowth.

scholarly journals Beta-Lactams Toxicity in the Intensive Care Unit: An Underestimated Collateral Damage?

2021 ◽  
Vol 9 (7) ◽  
pp. 1505
Author(s):  
Claire Roger ◽  
Benjamin Louart
Keyword(s):  
Risk Factors ◽  
Intensive Care Unit ◽  
Intensive Care ◽  
Clinical Manifestations ◽  
Acute Interstitial Nephritis ◽  
Convulsive Status Epilepticus ◽  
Beta Lactam ◽  
Beta Lactams ◽  
Drug Induced ◽  
Icu Patients

Beta-lactams are the most commonly prescribed antimicrobials in intensive care unit (ICU) settings and remain one of the safest antimicrobials prescribed. However, the misdiagnosis of beta-lactam-related adverse events may alter ICU patient management and impact clinical outcomes. To describe the clinical manifestations, risk factors and beta-lactam-induced neurological and renal adverse effects in the ICU setting, we performed a comprehensive literature review via an electronic search on PubMed up to April 2021 to provide updated clinical data. Beta-lactam neurotoxicity occurs in 10–15% of ICU patients and may be responsible for a large panel of clinical manifestations, ranging from confusion, encephalopathy and hallucinations to myoclonus, convulsions and non-convulsive status epilepticus. Renal impairment, underlying brain abnormalities and advanced age have been recognized as the main risk factors for neurotoxicity. In ICU patients, trough concentrations above 22 mg/L for cefepime, 64 mg/L for meropenem, 125 mg/L for flucloxacillin and 360 mg/L for piperacillin (used without tazobactam) are associated with neurotoxicity in 50% of patients. Even though renal complications (especially severe complications, such as acute interstitial nephritis, renal damage associated with drug induced hemolytic anemia and renal obstruction by crystallization) remain rare, there is compelling evidence of increased nephrotoxicity using well-known nephrotoxic drugs such as vancomycin combined with beta-lactams. Treatment mainly relies on the discontinuation of the offending drug but in the near future, antimicrobial optimal dosing regimens should be defined, not only based on pharmacokinetics/pharmacodynamic (PK/PD) targets associated with clinical and microbiological efficacy, but also on PK/toxicodynamic targets. The use of dosing software may help to achieve these goals.

scholarly journals Connective Tissue Metabolism and Gingival Overgrowth

2004 ◽  
Vol 15 (3) ◽  
pp. 165-175 ◽  
Author(s):  
P. C. Trackman ◽  
A. Kantarci
Keyword(s):  
Extracellular Matrix ◽  
Connective Tissue ◽  
Oral Hygiene ◽  
Tissue Specificity ◽  
Gingival Fibroblast ◽  
Drug Induced ◽  
Gingival Overgrowth ◽  
Connective Tissue Metabolism ◽  
Matrix Metabolism ◽  
Systemic Health

Gingival overgrowth occurs mainly as a result of certain anti-seizure, immunosuppressive, or antihypertensive drug therapies. Excess gingival tissues impede oral function and are disfiguring. Effective oral hygiene is compromised in the presence of gingival overgrowth, and it is now recognized that this may have negative implications for the systemic health of affected patients. Recent studies indicate that cytokine balances are abnormal in drug-induced forms of gingival overgrowth. Data supporting molecular and cellular characteristics that distinguish different forms of gingival overgrowth are summarized, and aspects of gingival fibroblast extracellular matrix metabolism that are unique to gingival tissues and cells are reviewed. Abnormal cytokine balances derived principally from lymphocytes and macrophages, and unique aspects of gingival extracellular matrix metabolism, are elements of a working model presented to facilitate our gaining a better understanding of mechanisms and of the tissue specificity of gingival overgrowth.

Spironolactone-Induced Agranulocytosis

1997 ◽  
Vol 31 (5) ◽  
pp. 582-585 ◽  
Author(s):  
Anna M Whitling ◽  
Pablo E Pérgola ◽  
John Lee Sang ◽  
Robert L Talbert
Keyword(s):  
Risk Factors ◽  
Adverse Effect ◽  
Bone Marrow ◽  
Leukocyte Count ◽  
Laboratory Data ◽  
University Hospital ◽  
Drug Induced ◽  
Bone Marrow Biopsies ◽  
Case Summary ◽  
Before And After

OBJECTIVE: TO report a case of agranulocytosis secondary to spironolactone in a patient with cryptogenic liver disease. CASE SUMMARY: A 58-year-old Hispanic woman with cryptogenic cirrhosis was admitted to University Hospital on October 31, 1995. Laboratory data revealed a leukocyte count of 1.0 × 103/mm3 and an absolute neutrophil count (ANC) of 10 cells/mm3. Prior to treatment with spironolactone, the leukocyte count was 10.2 × 103/mm3 and ANC 8400 cells/mm3. Agranulocytosis resolved 5 days following the discontinuation of spironolactone. Results from the bone marrow biopsies before and after treatment with spironolactone suggested that agranulocytosis was caused by the drug's toxic effect on the bone marrow. DISCUSSION: Drug-induced agranulocytosis is a serious adverse effect, occurring at a rate of approximately 6.2 cases per million persons each year. In addition to the case reported here, three other reports of agranulocytosis secondary to spironolactone have been published in the literature. Several factors have been identified that may increase a patient's risk for developing agranulocytosis, including increased age, hepatic or renal impairment, drag dosage and duration, and concurrent medications. CONCLUSIONS: Agranulocytosis secondary to spironolactone is a serious potential adverse effect. Patients with risk factors for developing this adverse effect should be closely monitored since early detection and discontinuation of spironolactone can improve prognosis.

Sign in / Sign up

Export Citation Format

Share Document